Jemapete Christopher J 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 10:44 am Unchanged | 2022-12-31 | 13G | Gene Biotherapeutics, Inc. CRXM | Jemapete Christopher J | 4,000,000 6.200% | 0 (Unchanged) | Filing |
| 2021-04-28 4:20 pm Unchanged | 2021-03-31 | 13G | Gene Biotherapeutics, Inc. CRXM | Jemapete Christopher J | 4,000,000 8.100% | 0 (Unchanged) | Filing |
| 2021-03-18 2:05 pm Purchase | 2021-03-16 | 13D | Gene Biotherapeutics, Inc. CRXM | Jemapete Christopher J | 4,000,000 27.600% | 500,000 (+14.29%) | Filing |
| 2021-03-01 4:48 pm Purchase | 2021-02-25 | 13D | Gene Biotherapeutics, Inc. CRXM | Jemapete Christopher J | 3,500,000 24.200% | 3,500,000 (New Position) | Filing |